End clap for “legal cannabis”. The National Agency for the Safety of Medicines and Health Products (ANSM) issued its verdict on the consumption of hexahydrocannabinol (HHC) products on Monday, June 12. Currently on free sale in France, this cannabis derivative will be banned for sale and consumption as of Tuesday, the agency announced in a press release. The decision is justified by a study showing “a risk of abuse and dependence equivalent to that of cannabis”.
“As I promised, the HHC has been assessed and is now classified as narcotic by the ANSM”, rejoiced the Minister of Health, François Braun, on social networks. “As of tomorrow, the consumption and sale of HHC will be prohibited. My ministry is mobilized to protect the health of French people and fight against addictions, ”he continues.
As promised, HHC has been assessed and is now classified as narcotic by @ansm. From tomorrow, the consumption and sale of HHC will be prohibited. My ministry @Sante_Gouv is mobilized to protect the health of French people and fight against addictions.
Just like pure cannabis, it provides euphoric and high effects. It also poses risks for its users: “Trembling, vomiting, anxiety, bad trip, mental confusion, tachycardia, chest pain…”, lists the ANSM. Note that HHC is different from cannabidiol (CBD), which remains authorized for sale and consumption in France.
Like France, other European countries have already banned the sale of HHC. This is the case of Austria, the United Kingdom, Belgium and even Denmark.